A critical component to ensuring a treatment or medical device is safe for use is the Bacterial Endotoxins Test (BET). Compendial BET methods include the gel-clot and kinetic LAL test, but their accuracy can only be as good as the validation performed on them.
Whether you’re new to endotoxin product validations or just need a refresher, this webinar will provide you with information on the steps necessary for LAL product validation, how they’re different for gel-clot and kinetic methods, and product validation examples following guidance from the USP and EP.
Hayden Skalski, BS
Endosafe® Technology and Market Development Manager, Charles River
- Endotoxin Testing Limits, Method Development and Validation for Plasma-Derived Products
- Product Validation Using the Endosafe®-MCS™
We are providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.